Affiliation
Cancer Research Campaign Department of Experimental Haematology, Paterson Institute for Cancer Research, Manchester, UK.Issue Date
1992-01-02
Metadata
Show full item recordAbstract
We have investigated the kinetics of myeloid cell proliferation in the marrow of patients with small-cell lung cancer and treated with 10 daily subcutaneous injections of granulocyte/macrophage colony-stimulating factor (GM-CSF). Bone marrow, obtained before and during treatment with the growth factor, was labelled in vitro with tritiated thymidine (3H-TdR). A 3rd bone-marrow sample was obtained 1 hr following an intravenous injection of 3H-TdR. Subsequent daily blood samples were also collected, and 3H-TdR labelling was assessed on these and the marrow preparations by autoradiography. GM-CSF treatment increased the peripheral granulocytic cells nearly 5-fold, but this included significant eosinophilia, so that the neutrophilic granulocytes increased only 3.3-fold. These cells were released from the marrow over a normal time scale, but their peripheral half-life was about 6 times longer than normal and they were probably functionally defective. Furthermore, significant numbers of immature cells were released from the marrow. Neutrophil production stimulated by GM-CSF was thus overestimated by measurement of the apparent peripheral granulocytosis. Increased labelling indices and grain counts in the proliferating granulocytic cells of the marrow indicate shortened cell-cycle times, and the excess granulocyte production appears to be the result of extra amplification divisions in the proliferative compartments.Citation
Haemopoietic cell kinetics in humans treated with rGM-CSF. 1992, 50 (1):26-31 Int J CancerJournal
International Journal of CancerPubMed ID
1370226Type
ArticleLanguage
enISSN
0020-7136Related articles
- Myeloid cell kinetics in response to haemopoietic growth factors.
- Authors: Lord BI
- Issue date: 1992 Jul
- Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte/macrophage colony-stimulating factor in combination.
- Authors: Lord BI, Testa NG, Bretti S, Chang J, Demuynck H, Coutinho L, de Campos E, Fitzsimmons L, Scarffe JH
- Issue date: 1994 Nov 15
- Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo.
- Authors: Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ, Dexter TM
- Issue date: 1991 May 15
- Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis in normal cats.
- Authors: Fulton R, Gasper PW, Ogilvie GK, Boone TC, Dornsife RE
- Issue date: 1991 Sep
- Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
- Authors: Keller JR, Jacobsen SE, Sill KT, Ellingsworth LR, Ruscetti FW
- Issue date: 1991 Aug 15